Researchers at Marina Biotech have identified new DiLA2-based formulations composed of multiple DiLA2 molecules, that when paired with a UsiRNA targeting FVII mRNA in liver (hepatocytes) of mice,
Synthon has also completed registration procedures for Tamsulosin, reported PharmaLive.com. Tamsulosin, an a1a-selective alpha blocker, contains the active ingredient Tamsulosin hydrochloride. Developed by Yamanouchi Pharmaceuticals (now part of
In exchange for the technology, BioSante received a 19.9% ownership position in Cold Genesys and a $95,000 upfront cash payment and is eligible to receive future milestone and
The updated data showed that the median time to progression for patients receiving Zybrestat plus bevacizumab and chemotherapy was 9.5 months, compared with a median time to progression
In the trial, patients received a recommended dose of 267mg/m2 by intravenous infusion over 2 hours, with retreatment every 3 weeks, for up to 6 courses. Aeterna Zentaris
Under the Department of Defense Prostate Cancer Research Program (PCRP) of the Office of the Congressionally Directed Medical Research Programs (CDMRP), STA-9584 is approved for funding of approximately
The Hyderabad-based Aurobindo Pharma is expected to sign an agreement regarding this with Pfizer, reported The Financial Express. Currently, Aurobindo is in pact with Pfizer for the marketing
Under the terms of their partnership agreement signed in January 2010, Inspiration in-licensed OBI-1 from Ipsen, and is responsible for the clinical development, regulatory process and commercialisation of
The first product in the new line is Allegro CTMS@Site, the clinical trials management system built exclusively for investigational sites. Forte Research claimed that the Allegro product line
Under terms of the agreement, Cardium will identify a line of products applying BioZone technology such as that incorporated into its QuSome, Inflacin, LipoCeutical, LipoSpray and other formulation
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.